The ESG mess aftermath costs dearly
21/09/22 -"Orpea’s latest communication foresaw lingering reputational risks, serious inflation effects (which seem hard to be recovered from the residents’ side in the short term) and additional ..."
Pages
55
Language
English
Published on
21/09/22
You may also be interested by these reports :
12/09/25
DiaSorin appears to be making significant progress in the testing space. The launch of speciality tests, introduction of the Plex platform, and ...
05/09/25
Bastide reported FY24/25 revenue in line with guidance and our forecast. The more technical business activities remain the primary driver of organic ...
05/09/25
Since we last pushed Philips’ (Buy; Netherlands) investment case in January 2024, its share price performance has been glaringly ahead of the MedTech ...
04/09/25
bioMerieux’s H1 profitability surpassed expectations. Topline growth was driven by robust performance across both segments. However, weakness in ...